http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100958045-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100958045-B1 |
| titleOfInvention | Agents containing 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol and having a delayed release of the active ingredient |
| abstract | The present invention relates to pharmaceutical formulations characterized in that the release of the active ingredient is delayed. The formulation contains one of 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol or a pharmaceutically acceptable salt thereof in the matrix to which the release of the active ingredient is delayed. The matrix contains 1 to 80% by weight of one or more hydrophilic or hydrophobic polymers as a pharmaceutically acceptable matrix former and exhibits the following dissolution rate in vitro: relative to 100% by weight of active ingredient, 3- (3-dimethyl 3 to 35% by weight of amino-1-ethyl-2-methyl-propyl) phenol is released after 30 minutes, and 5 to 50% by weight of 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol Released after 1 hour, and 10 to 75% by weight of 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol was released after 2 hours, and 3- (3-dimethylamino-1-ethyl-2 15-82% by weight of -methyl-propyl) phenol is released after 3 hours, 30-97% by weight of 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol is released after 6 hours, 3 50 weight% or more of-(3-dimethylamino-1-ethyl-2-methyl-propyl) phenol is released after 12 hours, and 70 weight of 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol More than 18:00 After being released, 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol of 80% or more is released after 24 hours. n n n n 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) phenol, delayed release, matrix, hydrophilic or hydrophobic polymer, matrix former |
| priorityDate | 2001-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.